January 2013 Editor's Picks: Products from Cole-Parmer and Yokogawa - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

January 2013 Editor's Picks: Products from Cole-Parmer and Yokogawa

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Cole-Parmer
Portable freezer offers secure, low-temperature transport

The Shuttle Portable Ultra-Low Temperature Freezer from Cole-Parmer is lightweight (42 lbs.), maintains temperatures from −86 to −20 °C, and can be secured. The portable freezer is efficient for both benchtop and field uses, and can be used for transporting vaccines or biological specimens. A weather-resistant touchpad digitally indicates interior temperature and error codes. The freezer’s cabinet, which uses composite vacuum-insulation panels with CFC-free foam, withstands travel. The freezer is energy efficient, and is operated by an engine that uses the same energy as a conventional light bulb.

Yokogawa
Dual bent-tube coriolis meter measures liquid and gas flow at low rates


Yokogawa’s RotaMass LR is, according to the company, the world’s smallest dual bent-tube coriolis meter, and it is designed for accurate and stable measurement of fluids at low flow rates. The meter measures mass flow of gases or liquids from 0–40 kg/h, with an accuracy of +/- 0.15% for liquids and +/- 0.5% for gases. The dual bent-tube design decouples the core-measuring element from process vibration that can cause fluctuating zero stability and decrease measurement accuracy. It is also insensitive to fluctuations in ambient temperature. Although tubes with a smaller surface area normally make it more difficult to measure temperature, the RotaMass LR solves this problem by using an inline temperature sensor that ensures exact and fast measurements in process temperatures ranging from −50 to +150 °C.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Equipment and Processing Report,
Click here